Levamisole


Concise Prescribing Info
Indications/Uses
Listed in Dosage.
Dosage/Direction for Use
Adult: PO Ascariasis 150 mg as a single dose. Ancylostomiasis; Mixed-ascariasis hookworm infections 2.5 mg/kg as a single dose, repeat after 7 days for severe cases.
Administration
Should be taken with food. Take w/ meals to minimise side effects eg, nausea.
Contraindications
Preexisting blood disorders; pregnancy and lactation; rheumatoid arthritis; severe renal impairment.
Special Precautions
Hepatic impairment, Sjogren's syndrome.
Adverse Reactions
Nausea, vomiting, diarrhoea, abdominal pain, dizziness and headache. Fever, influenza-like syndrome, arthralgia, muscle pain, rash, taste disturbances and cutaneous vasculitis.
Potentially Fatal: Agranulocytosis, leucopenia, thrombocytopenia.
Drug Interactions
May increase toxicity of phenytoin. Increases bioavailability of ivermectin; decreases bioavailability of albendazole. Alcohol causes disulfiram-like reaction.
ATC Classification
P02CE01 - levamisole ; Belongs to the class of imidazothiazole derivative agents. Used as antinematodal.
Disclaimer: This information is independently developed by CIMS based on levamisole from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in